| Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
|---|---|---|---|---|---|
| 28-Jun-26 | Interim | 2,289.10 | 11.80 | 25.70p | 10.10p |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 02-Jan-22 | 3,301.97 | 47.40 | 61.30p | 18.6 | 1.7 | +11% | 29.70p | 2.6% |
| 01-Jan-23 | 3,847.60 | 29.61 | 45.10p | 12.4 | n/a | -26% | 29.70p | 5.3% |
| 31-Dec-23 | 3,989.50 | 48.60 | 52.80p | 15.2 | 0.9 | +17% | 32.00p | 4.0% |
| 29-Dec-24 | 3,821.40 | 57.40 | 56.60p | 15.8 | 2.3 | +7% | 34.50p | 3.9% |
| 28-Dec-25 | 4,214.60 | 56.10 | 52.70p | 9.5 | n/a | -7% | 35.00p | 7.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 4,419.83 | 90.08 | 50.05p | 13.3 | n/a | n/a | 35.51p | 0.0% |
| 31-Dec-27 | 4,594.25 | 96.63 | 55.45p | 12.0 | 1.1 | +11% | 35.76p | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| 5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
|---|---|---|---|---|
| Latest | 18.60 | 9.47 | 14.28 | 0.73 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
| Currency | UK Pounds |
| Share Price | 666.50p |
| Change Today | -1.00p |
| % Change | -0.15 % |
| 52 Week High | 710.00 |
| 52 Week Low | 456.00 |
| Volume | 94,542 |
| Shares Issued | 89.96m |
| Market Cap | £599.55m |
| RiskGrade | 184 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 4 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 5 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 29-Oct-26 | 28-May-26 |
| Paid | 27-Nov-26 | 26-Jun-26 |
| Amount | 10.10p | 24.90p |
| Time | Volume / Share Price |
| 16:35 | 797 @ 666.50p |
| 16:35 | 365 @ 666.50p |
| 16:35 | 1,749 @ 666.50p |
| 16:35 | 48 @ 666.50p |
| 16:35 | 133 @ 666.50p |
| CFO | Matt Osborne |
| CEO | Mark Allen |
| Chair | Mark Clare |
You are here: research